Cargando…
Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer
We herein report a 74-year-old man who developed Lambert-Eaton myasthenic syndrome (LEMS) during atezolizumab treatment for extensive-stage small-cell lung cancer. He was started on maintenance immunotherapy with atezolizumab every three weeks after four cycles of atezolizumab plus carboplatin plus...
Autores principales: | Kunii, Eiji, Owaki, Sota, Yamada, Kazuki, Yoshihara, Misuzu, Yamaba, Yusuke, Takakuwa, Osamu, Toyoda, Takanari, Akita, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259317/ https://www.ncbi.nlm.nih.gov/pubmed/34707051 http://dx.doi.org/10.2169/internalmedicine.8387-21 |
Ejemplares similares
-
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer
por: Yamazoe, Masami, et al.
Publicado: (2023) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
por: Gilhus, Nils Erik
Publicado: (2011) -
Lambert-Eaton Myasthenic syndrome: early diagnosis is key
por: Ivanovski, Trajche, et al.
Publicado: (2019)